Management of Hepatoblastoma in the Modern Era and Future Perspectives
Jin-Kyung SUH; Sunghan KANG; Hyery KIM; Kyung-Nam KOH; Ho-Joon IM.
Clinical Pediatric Hematology-Oncology
; : 43-54, 2020.
ArtÃculo | WPRIM | ID: wpr-832096
Documentos relacionados
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
Construction of web<b>-</b>based prediction nomogram models for cancer<b>-</b>specific survival in patients at stage IV of hepatocellular carcinoma depending on SEER database.
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study.
The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
[Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Biomedical research in france and brazil: an analysis of significant differences and ethical issues
Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma.
Liver transplantation for Hepatocellular Carcinoma: A prognostic model incorporating pretransplant inflammatory cytokines.